About Protego Biopharma
Protego Biopharma is a private company based in San Diego, California. It has reported $84,989,544 raised in three offerings on Form D since December 2019. Its chief executive is Brent Warner.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 17, 2025 | Dec 3, 2025 | $32,942,190of $130.4M target | 18 | $1.8M | EquityRule 506(b) | Form D ↗ |
| Oct 19, 2021 | Oct 28, 2021 | $51,047,342fully sold | 6 | $8.5M | EquityRule 506(b) | Form D ↗ |
| Dec 6, 2019 | Dec 17, 2019 | $1,000,012fully sold | 3 | $333K | Equity, Options, Securities on exerciseRule 504, Rule 506(b), 4a5 | Form D ↗ |
| Total, three offerings | $84,989,544 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Protego Biopharma's Form D filed Dec 3, 2025.
TL
Tim Lohoff
Director
EH
Edward Hurwitz
Director
HP
Hank Petrassi
Executive officer
JN
Janwillem Naesens
Director
SH
Saoussen Ben Halima
Director
LB
Laura Brass
Director
JK
Jeffery Kelly
Director
BW
Brent Warner
Chief Executive Officer and director
SC
Shelley Chu
Director
HK
Helen Kim
Director
Earlier filings also listed Richard Labaudiniere (chief executive officer and director, last listed Oct 2021), Jeffrey Kelly (director, last listed Oct 2021) and Xin Jiang (president & ceo, last listed Dec 2019).